Bolt Biotherapeutics
Diane Carrera is a highly experienced professional in the field of chemistry and bioconjugation, currently serving as Senior Director and Head of Chemistry and Bioconjugation at Bolt Biotherapeutics, Inc. since November 2019. Previous roles include Director and Associate Director of Process Chemistry at the same company, and Scientist and Associate Scientist at Genentech, where responsibilities included synthetic route discovery, optimization, and kilo-lab scale-up under GMP conditions. Early career experience includes a position as a Research Assistant at Johnson & Johnson, focused on generating small molecule libraries of GPCR antagonists. Diane Carrera holds a Ph.D. in Organic Chemistry from Caltech and a B.S. in Chemistry from Stanford University.
This person is not in any teams
This person is not in any offices
Bolt Biotherapeutics
6 followers
Bolt Biotherapeutics, Inc., based in the San Francisco Bay Area, is a publicly-traded biotechnology company developing Boltbody™ Immune-stimulating Antibody Conjugates (ISAC), a new class of immuno-oncology therapeutics that have eliminated tumors following systemic administration in preclinical studies and results in the development of immunological memory, which may lead to more durable clinical responses for patients.